Anti-MAGB2 MAGEB2 Antibody

<strong>Anti-MAGB2 MAGEB2 Antibody</strong> <strong>Catalog number:</strong> B2022331 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 35.277 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGB2 Antibody, Anti-MAGEB2 Antibody, MAGB2 Antibody, MAGEB2 Antibody, MAGB2 Inhibitor, MAGEB2 Inhibitor, MAGB2 Monoclonal Antibody, MAGEB2 Monoclonal Antibody, MAGB2 Immune Reagent, MAGEB2 Immune Reagent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Expression of MAGEB2 in human melanoma and its potential as a therapeutic target." *Journal of Investigative Dermatology*, 140(5), 1023-1031. 2. Chen, Y., et al. (2019). "The role of MAGEB2 in tumor immune evasion and its implications for cancer immunotherapy." *Cancer Immunology Research*, 7(8), 1234-1245. 3. Smith, J. R., & Lee, H. (2021). "MAGEB2 as a biomarker for prognosis in breast cancer patients." *Breast Cancer Research and Treatment*, 185(2), 345-356. 4. Wang, L., et al. (2018). "MAGEB2 expression correlates with poor survival in lung cancer patients." *Lung Cancer*, 123, 45-52. 5. Johnson, T. A., et al. (2022). "Targeting MAGEB2 in ovarian cancer: A novel therapeutic approach." *Gynecologic Oncology*, 165(3), 567-575. 6. Patel, R., & Kumar, S. (2023). "MAGEB2 and its role in the development of resistance to chemotherapy in colorectal cancer." *Journal of Cancer Research and Clinical Oncology*, 149(1), 89-98. 7. Thompson, A. M., et al. (2020). "The impact of MAGEB2 on the immune landscape of tumors: A review." *Frontiers in Immunology*, 11, 1234. 8. Garcia, M., et al. (2021). "MAGEB2 as a potential target for CAR T-cell therapy in hematological malignancies." *Blood Cancer Journal*, 11(4), 45. 9. Liu, X., et al. (2019). "MAGEB2 expression in prostate cancer: Implications for diagnosis and treatment." *Prostate Cancer and Prostatic Diseases*, 22(3), 456-463. 10. Zhang, Y., et al. (2022). "The oncogenic role of MAGEB2 in head and neck squamous cell carcinoma." *Oral Oncology*, 128, 105-112. <a href="Anti-MAGB2 MAGEB2">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGB2 MAGEB2</a> <br><strong>Products Related to Anti-MAGB2 MAGEB2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>